Document is current
Any future updates will be listed below
-
Authors
Dekker, Esther N.
Janssen, Quisette P.
van Dam, Jacob L.
Strijk, Gaby J.
Verkolf, Eva M. M.
Kandala, Sridhar
Dumas, Jasper
Fellah, Amine
O’Reilly, Eileen M.
Besselink, Marc G.
van Eijck, Casper H. J.
Homs, Marjolein Y. V.
van Tienhoven, Geert-Jan
Wilmink, Johanna W.
Mustafa, Dana A. M.
Groot Koerkamp, Bas https://orcid.org/0000-0003-1917-6973
,
Beerepoot, L. V.
van Bekkum, M. L.
Bonsing, B. A.
Bos, H.
Bosscha, K. P.
Bouwense, S. A.
Brouwer-Hol, L.
Bruynzeel, A. M. E.
Busch, O. R.
Cirkel, G.
Coene, P. P. L. O.
de Groot, J. W. B.
Haberkorn, B. C. M.
de Hingh, I. H. J. T.
Karsten, T. M.
Kazemier, G.
van der Kolk, M. B.
Liem, M. S. L.
Loosveld, O. J. L.
Luelmo, S. A. C.
Luyer, C. M.
Mieog, J. S. D.
Nieuwenhuijs, V. B.
Nuyttens, J. J. M. E.
ten Oever, D.
Patijn, G. A.
van Santvoort, H. C.
Stommel, M. W. J.
Streppel, M. M.
ten Tije, A.
Versteijne, E.
de Vos - Geelen, J.
de Wilde, R. F.
-
Funding
Funding for this research was provided by:
ZonMw (843004108)
KWF Kankerbestrijding (10955)
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 2 January 2025
First Online: 5 February 2025
Disclosure
: Eileen M. O’Reilly received research funding for the institution from Genentech/Roche, BioNTech, AstraZeneca, Arcus, Elicio, Parker Institute, NIH/NCI, and Digestive Care. She is consulting/DSMB for Arcus, Ability Pharma, Alligator Bioscience, BioNTech, Ipsen, Merck, Novartis, Syros, Leap Therapeutics, Astellas, Autem, BMS, Revolution Medicine, Tempus, Fibrogen, Merus, Revi Agios (spouse), Genentech-Roche (spouse), Eisai (spouse), and Servier (Spouse). Johanna W. Wilmink is consulting/advisor for MSD, Servier, Novartis, Astra Zeneca, and Nordic. She has received research funding for the institution from Servier, Nordic, and MSD. Casper H. J. van Eijck is consultant for AIM ImunnoTech. The remaining authors have no conflicts of interest.
